EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Celso Arango, Joerg M Fegert, Françoise Picarel-Blanchot, Ute Marx, Lucie Truffaut-Chalet, Pierre-François Pénélaud, Jan Buitelaar, study investigators

European Child & Adolescent Psychiatry · 2025

DOI: 10.1007/s00787-024-02587-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Celso Arango und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIB…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Acetamides, Fluoxetine, Antidepressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Servier France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderAcetamidesFluoxetineAntidepressive AgentsHumansFemaleAdolescentMaleDouble-Blind MethodChildTreatment OutcomeNaphthalenes

Stichwörter der Autor:innen

AdolescentAgomelatineChildrenMajor depressive disorderOpen-label extensionPediatric

Substanzen

agomelatineAcetamidesFluoxetineAntidepressive AgentsNaphthalenes

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
  • Universitätsklinikum Ulm, Steinhövelstraße 5, 89075, Ulm, Germany.
  • Servier Medical and Patient Affairs, Suresnes, France.
  • Servier Forschung und Pharmaentwicklung, Munich, Germany. ute.marx@servier.com.
  • Servier Global Biometrics, Suresnes, France.
  • Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.

Förderung

  • Servier France

Zitieren

APA

Arango, C., Fegert, J. M., Picarel-Blanchot, F., Marx, U., Truffaut-Chalet, L., Pénélaud, P. F., Buitelaar, J., & study investigators (2025). Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-024-02587-4

Vancouver

Arango C, Fegert JM, Picarel-Blanchot F, Marx U, Truffaut-Chalet L, Pénélaud PF, et al. Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-024-02587-4

BibTeX
@article{Arango2025,
  author = {Arango, Celso and Fegert, Joerg M and Picarel-Blanchot, Françoise and Marx, Ute and Truffaut-Chalet, Lucie and Pénélaud, Pierre-François and Buitelaar, Jan and study investigators, study investigators},
  title = {Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study},
  journal = {European Child & Adolescent Psychiatry},
  year = {2025},
  doi = {10.1007/s00787-024-02587-4}
}
Kostenlos starten →